Sort
51,593 grants matching “hepatitis”
HCV Genomic Variability in HIV Infected Hemophiliacs
$722,752University Of Cincinnati · R01 · FY2004 · AI
The circadian rhythm as a lentiviral vector restriction factor
$722,551Tal Kafri · Univ Of North Carolina Chapel Hill · R01 · FY2023 · HL
Extracellular Matrix Regulates Hepatic Stellate Cell Activation and Fibrosis
$722,531Ekihiro Seki · Cedars-Sinai Medical Center · R01 · FY2025 · DK
Thyroid Hormone Receptors in Health and Disease
$722,498Sheue-Yann Cheng · Division Of Basic Sciences - Nci · ZIA · FY2009 · CA
Functional connectivity mechanisms of opioid abstinence
$722,366Sarah Yip · Yale University · R01 · FY2024 · DA
Behavioral Assessment and Medical (BAM) Core
$722,362Robert Kernachan Heaton · University Of California, San Diego · P50 · FY2016 · DA
Antisense Mediated Treatment of Hepatitis B Virus Infection
$722,183Stefan Frank Wieland · Scripps Research Institute, The · R01 · FY2013 · AI
Evaluation of a persuasive health communication intervention designed to increase HIV/HCV screening among emergency departments patients who currently, formerly or never injected drugs
$722,124Roland C Merchant · Icahn School Of Medicine At Mount Sinai · R01 · FY2024 · DA
STD and AIDS Research Training Grant
$721,965Anna Wald · University Of Washington · T32 · FY2023 · AI
Metabolic Markers and Predictors of Childhood Obesity
$721,811Sonia Caprio · Yale University · R01 · FY2020 · HD
COMPLEMENT AND CYTOKINE NETWORK IN LIVER REGENERATION
$721,764John D Lambris · University Of Pennsylvania · P01 · FY2009 · AI
Therapeutic and mechanistic significance of altered metabolism of HIV medicines by alcohol- or alcohol/synthetic opioid combination
$721,672Bingfang Yan · University Of Cincinnati · R01 · FY2022 · AA
Role of mitochondrial extracellular vesicles in CVB3 myocarditis by sex
$721,646Delisa Fairweather · Mayo Clinic Jacksonville · R01 · FY2025 · HL
Mechanism of ultrasound neuromodulation effects on glucose homeostasis and diabetes
$721,529Raimund Ingo Herzog · Yale University · R01 · FY2024 · DK
Brain-penetrating acetylcholinesterase reactivators for several organophosphates
$721,494Janice E. Chambers · Mississippi State University · U01 · FY2014 · NS
Brain-penetrating acetylcholinesterase reactivators for several organophosphates
$721,494Janice E. Chambers · Mississippi State University · U01 · FY2016 · NS
Gamma Delta T cell and microbial modulation to target chronic SIV-associated inflammation
$721,380Namita Rout · Tulane University Of Louisiana · R01 · FY2025 · DK
Smartphone Enabled Point-of-Care Detection of Serum Markers of Liver Cancer
$721,330Ashutosh Chilkoti · Duke University · UH3 · FY2020 · CA
Oxytocin as a Neuroendocrine Therapy for Obesity in Youth
$721,328Elizabeth Austen Lawson · Massachusetts General Hospital · R01 · FY2023 · DK
Oxytocin as a Neuroendocrine Therapy for Obesity in Youth
$721,328Elizabeth Austen Lawson · Massachusetts General Hospital · R01 · FY2025 · DK
Effect of PCSK9 Inhibition on Cardiovascular Risk in Treated HIV Infection (EPIC-HIV Study)
$721,297Priscilla Y. Hsue · University Of California, San Francisco · R33 · FY2022 · HL
Effect of PCSK9 Inhibition on Cardiovascular Risk in Treated HIV Infection (EPIC-HIV Study)
$721,297Priscilla Y. Hsue · University Of California, San Francisco · R33 · FY2021 · HL
Effect of PCSK9 Inhibition on Cardiovascular Risk in Treated HIV Infection (EPIC-HIV Study)
$721,297Priscilla Y. Hsue · University Of California, San Francisco · R33 · FY2020 · HL
HIV and Hepatocellular Carcinoma in Uganda: The H2U Consortium
$721,268Gregory D Kirk · Johns Hopkins University · U54 · FY2017 · CA
Effects of Anti-miR-33 on Atherosclerosis Regression and RCT in Nonhuman Primates
$721,178Ryan Eugene Temel · University Of Kentucky · R01 · FY2017 · HL